Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Christian Salinas

Vascular & Interventional Radiology Myrtle Beach, SC Medical Doctor

NPI 1306109756 CMS profile 598765

809 82Nd Pkwy, Myrtle Beach, SC 29572

Open in the dashboard

General payments

$6,533

288 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Christian Salinas of Myrtle Beach, SC is reported in the CMS Open Payments database as having received $6,533 across 288 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 69th percentile of Vascular & Interventional Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,674 153
2024 General $2,173 93
2023 General $518 17
2022 General $86 4
2021 General $371 9
2020 General $243 4
2019 General $467 8

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Christian Salinas
  • Vascular & Interventional Radiology median
  • Middle half of Vascular & Interventional Radiology
  • National median

In program year 2025, general payments to Christian Salinas were reported at $2,674. Among 3,393 Vascular & Interventional Radiology profiles paid that year, the median was $534 and the middle half received between $166 and $2,075.

Show as a table
Year Christian Salinas Vascular & Interventional Radiology median Middle half National median
2019 $467 $422 $125–$1,555 $163
2020 $243 $200 $68–$652 $114
2021 $371 $280 $99–$866 $132
2022 $86 $433 $137–$1,497 $149
2023 $518 $506 $152–$2,019 $160
2024 $2,173 $556 $175–$1,930 $164
2025 $2,674 $534 $166–$2,075 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Inari Medical, Inc. $2,636 92 payments
  2. Stryker Corporation $1,649 107 payments
  3. Medtronic, Inc. $380 22 payments
  4. Boston Scientific Corporation $236 13 payments
  5. Shockwave Medical, Inc $219 5 payments
  6. DePuy Synthes Sales Inc. $215 8 payments
  7. Imperative Care, INc $205 11 payments
  8. MicroVention, Inc. $148 1 payment
  9. Terumo Medical Corporation $139 3 payments
  10. Biocompatibles, Inc. $121 2 payments
  11. Other $586 24 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $6,485 287 payments
  2. Education $47 1 payment
Products named General payments · program years 2019–2025
  1. FLOWTRIEVER CATHETER, S $3,479 134 payments
  2. CT THROMBECTOMY SYSTEM KIT $2,960 128 payments
  3. FLOWTRIEVER Inari Medical $429 31 payments
  4. V-Trak System $295 2 payments
  5. ClotTriever $216 2 payments
  6. FlowTriever Venous Thrombectomy $216 2 payments
  7. HydroSoft 3D Coil $148 1 payment
  8. HyperSoft 3D Coil $148 1 payment
  9. HydroFrame Coil $148 1 payment
  10. AZUR $139 3 payments
  11. Other $2,463 129 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

11

Median for Diagnostic Radiology: 24

Drug cost

$227

Median for Diagnostic Radiology: $190

Branded share of claims

100%

Median for Diagnostic Radiology: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Clopidogrel Clopidogrel Bisulfate Brand 11 $227

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,198 Part D prescribers listed as Diagnostic Radiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 264 billing codes

Paid by Medicare

$187,892

Medicare's payments for the services billed

Medicare patients

2,606

Average age 75

Services billed

3,893

1,363 women, 1,243 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 59%
Ischemic heart disease 44%
Diabetes 37%
Chronic kidney disease 34%
Atrial fibrillation 32%
Heart failure 30%
COPD 29%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

288 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record